Idiopathic Hypersomnia clinical trials

Explore recruiting idiopathic hypersomnia clinical trials.

Recruiting idiopathic hypersomnia studies right now

Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record
Study details & eligibility ClinicalTrials.gov record

Also recruiting in Europe

Idiopathic Hypersomnia trials registered in the EU Clinical Trials Information System (CTIS). These are outside the "near me" matcher above - open a study for full details.

A Phase 2, Randomized, Parallel-Group, Double-Blind, Dose-Range-Finding Study to Evaluate the Safety and Efficacy of ALKS 2680 in Subjects With Idiopathic Hypersomnia

Italy, Belgium, Czechia, France, Netherlands, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

An Open-Label, Long-Term Extension Study to Investigate the Safety, Tolerability, and Durability of Treatment Effect of ALKS 2680 in Subjects With Narcolepsy Type 1 and Type 2 and Idiopathic Hypersomnia

Belgium, Netherlands, Czechia, Italy, France, Spain

Phase II and Phase III (Integrated) EU CTIS Study details

A randomized, double-blind, placebo-controlled trial comparing the efficacy and tolerance of solriamfetol in patients affected with idiopathic hypersomnia. SOLR-IH

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Dose-Finding, Adaptive, Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Safety, Tolerability, and Efficacy of TAK-360 in Participants with Idiopathic Hypersomnia (IH)

Italy, France, Spain

Therapeutic exploratory (Phase II) EU CTIS Study details

A CHRONOBIOLOGICAL TREATMENT combining evening melatonin and morning light therapy IN IDIOPATHIC HYPERSOMNIA: a prospective, double bind, randomized, placebo-controlled -trial

France

Therapeutic exploratory (Phase II) EU CTIS Study details

A Phase 2, Long-term Extension Study of the Safety and Efficacy of ORX750 in Participants with Narcolepsy and Idiopathic Hypersomnia Who Completed a Sponsored ORX750 Clinical Trial

France, Spain, Italy

Therapeutic exploratory (Phase II) EU CTIS Study details

Idiopathic Hypersomnia trials by city

Idiopathic Hypersomnia in Toronto Idiopathic Hypersomnia in Vancouver Idiopathic Hypersomnia in Montreal Idiopathic Hypersomnia in Calgary Idiopathic Hypersomnia in Edmonton Idiopathic Hypersomnia in Ottawa Idiopathic Hypersomnia in Winnipeg Idiopathic Hypersomnia in Quebec City Idiopathic Hypersomnia in Hamilton Idiopathic Hypersomnia in Kitchener Idiopathic Hypersomnia in London Idiopathic Hypersomnia in Halifax Idiopathic Hypersomnia in New York Idiopathic Hypersomnia in Los Angeles Idiopathic Hypersomnia in Chicago Idiopathic Hypersomnia in Houston

Other conditions

Obesity Type 2 diabetes Type 1 diabetes Prediabetes Weight loss Metabolic syndrome High cholesterol High triglycerides High blood pressure PCOS Hypothyroidism Thyroid disease Gout Fatty liver disease (NAFLD/NASH) Heart failure Coronary artery disease Atrial fibrillation Stroke Stroke recovery Peripheral artery disease Pulmonary hypertension Deep vein thrombosis Chronic kidney disease Diabetic kidney disease